Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corcept Therapeutics Inc shares valued at $430,475 were sold by Maduck Sean on Mar 18 ’24. At $25.00 per share, Maduck Sean sold 17,219 shares. The insider’s holdings dropped to 75,222 shares worth approximately $1.9 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Swisher Daniel N JR sold 2,200 shares, netting a total of over 51,898 in proceeds. Following the sale of shares at $23.59 each, the insider now holds 0 shares.
Before that, Maduck Sean had sold 27,068 shares from its account. In a trade valued at $702,905, the insider traded Corcept Therapeutics Inc shares for $25.97 each. Upon closing the transaction, the insider’s holdings decreased to 27,068 shares, worth approximately $1.89 million.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
During the last five days, there has been a surge of approximately 3.73%. Over the course of the year, Corcept Therapeutics Inc shares have dropped approximately -22.04%. Shares of the company reached a 52-week high of $27.54 on 01/08/24 and a 52-week low of $20.87 on 02/02/24. A 50-day SMA is recorded $23.37, while a 200-day SMA reached $26.41. Nevertheless, trading volume fell to 0.75 million shares from 0.85 million shares the previous day.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 24.82, which, if violated, would cause prices to drop to 24.32. In the upper region, resistance lies at 25.59. The next price resistance is at 25.86. RSI (Relative Strength Index) is 61.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.63, which suggests the price will decrease in the coming days. Percent R is at 1.48%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.58 million shares to 20.22 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 19.64 million shares. A jump of 2.87% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 18.88 of the overall float, the days-to-cover ratio (short ratio) jumped to 18.88.
